Ionis Pharmaceuticals Inc. – Credit Agreements

NASDAQ: IONS
Share price (3/25/26): $72.70
Market cap (3/25/26): $12.0 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

from 10-Q 36 pages Consent to Collateral Addition and Amendment to Loan Documents

from 8-K 153 pages Loan Agreement Dated as of July 18, 2017 Between Ionis Faraday, LLC as Borrower and Ubs AG, by and Through Its Branch Office at 1285 Avenue of the Americas, New York, New York, as Lender

from 8-K 153 pages Loan Agreement Dated as of July 18, 2017 Between Ionis Gazelle, LLC as Borrower and Ubs AG, by and Through Its Branch Office at 1285 Avenue of the Americas, New York, New York, as Lender

from 10-K 3 pages Amendment No. 2 to Line of Credit Agreement

from 8-K 3 pages Amendment No. 1 to Loan Documents

from 10-Q 39 pages Line of Credit Agreement by and Between ISIS Pharmaceuticals, Inc. as Borrower and Morgan Stanley Private Bank, National Association as Lender

from 10-Q 3 pages Third Amendment to Loan Agreement

from 10-K 2 pages Second Amendment to Loan Agreement

from 10-K 3 pages First Amendment to Loan Agreement

from 10-K 16 pages Loan Agreement

from 10-K ~20 pages Loan and Security Agreement Between Silicon Valley Bank and ISIS Pharmaceuticals, Inc. December 15, 2003 $32,000,000

from 10-Q ~10 pages Loan Agreement